Pralsetinib
ATC L01EX23 · 7 markets · 7 records
| Strength / form / release | US | GB | TW | HK |
|---|---|---|---|---|
| 100 mg capsule | Gavreto | Gavreto | Gavreto 普吉華膠囊100毫克 | |
unknown | Gavreto |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
1 more strength/form rows are recorded only in HK and are not shown in this table. Hay 1 filas de concentración/forma registradas solo en HK que no se muestran en esta tabla. 另有 1 个规格/剂型仅在 HK 有记录（未在本表显示）。 另有 1 個規格/劑型僅在 HK 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.